Last Modified on
May 26, 2023
OMMA is aware of issues that may affect pending commercial and patient applications submitted prior to June 1, 2023. We are working with our licensing vendor, Thentia, to address this issue. We will be flexible with our applicants while we work towards a resolution. We will update this banner once we have reached a resolution.
